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Abstract
Background: Pulmonary hyperinflation has the potential for significant adverse effects on cardiovascular function
in COPD. The aim of this study was to investigate the relationship between dynamic hyperinflation and
cardiovascular response to maximal exercise in COPD patients.
Methods: We studied 48 patients (16F; age 68 yrs ± 8; BMI 26 ± 4) with COPD. All patients performed spirometry,
plethysmography, lung diffusion capacity for carbon monoxide (TLco) measurement, and symptom-limited
cardiopulmonary exercise test (CPET). The end-expiratory lung volume (EELV) was evaluated during the CPET.
Cardiovascular response was assessed by change during exercise in oxygen pulse (ΔO2Pulse) and double product, i.
e. the product of systolic blood pressure and heart rate (DP reserve), and by the oxygen uptake efficiency slope
(OUES), i.e. the relation between oxygen uptake and ventilation.
Results: Patients with a peak exercise EELV (%TLC) ≥ 75% had a significantly lower resting FEV1/VC, FEF50/FIF50
ratio and IC/TLC ratio, when compared to patients with a peak exercise EELV (%TLC) < 75%. Dynamic
hyperinflation was strictly associated to a poor cardiovascular response to exercise: EELV (%TLC) showed a negative
correlation with ΔO2Pulse (r = - 0.476, p = 0.001), OUES (r = - 0.452, p = 0.001) and DP reserve (r = - 0.425, p =
0.004). Furthermore, according to the ROC curve method, ΔO2Pulse and DP reserve cut-off points which maximized
sensitivity and specificity, with respect to a EELV (% TLC) value ≥ 75% as a threshold value, were ≤ 5.5 mL/bpm
(0.640 sensitivity and 0.696 specificity) and ≤ 10,000 Hg · bpm (0.720 sensitivity and 0.783 specificity), respectively.
Conclusion: The present study shows that COPD patients with dynamic hyperinflation have a poor cardiovascular
response to exercise. This finding supports the view that in COPD patients, dynamic hyperinflation may affect
exercise performance not only by affecting ventilation, but also cardiac function.
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Introduction
Patients with COPD may develop pulmonary static
hyperinflation because of destruction of pulmonary par-
enchyma and loss of elastic recoil. In addition to or
independently from static hyperinflation, lung dynamic
hyperinflation of the lung may be observed at any stage
of COPD [1]. COPD patients with dynamic hyperinfla-
tion breathe in before achieving a full exhalation and, as
consequence, air is trapped within the lungs with each
further breath. Exertional dynamic hyperinflation implies
a minor expansion of tidal volume and massive loading
of inspiratory muscles with serious mechanical and sen-
sory repercussions [2].
Pulmonary hyperinflation has the potential for signifi-
cant adverse effects on cardiovascular function in
COPD. In patients with severe emphysema, left and
right ventricular performance was impaired because of
small end-diastolic dimensions evaluated by magnetic
resonance technique [3]. In these patients, decreased
biventricular preload was attributed to intrathoracic
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hypovolemia caused by hyperinflated lungs. Futhermore
in a population-based study, a greater extent of emphy-
sema on CT scanning was related to impaired left ven-
tricular filling, reduced stroke volume and lower cardiac
output [4].
To our knowledge only one study [5] showed a rela-
tionship between dynamic hyperinflation and cardiovas-
cular response in COPD patients performing a cycle
ergometry (incremental test). In this study, the authors
found that in patients with severe COPD, lower oxygen
pulse was associated with resting and dynamic hyperin-
flation. Oxygen pulse (O2Pulse) is considered as a mea-
sure of cardiovascular efficiency, since it indicates what
metabolic value in terms of oxygen uptake derives from
every heart beat. It is commonly used as an estimator of
stroke volume during exercise. However this remains
controversial, especially in patients who desaturate [6].
It is of note that cardiovascular response to exercise
may also be non invasively assessed by the double pro-
duct (DP) [7], i.e. the product of systolic blood pressure
and heart rate, and by the oxygen uptake efficiency
slope (OUES) [8], i.e. the relation between oxygen
uptake and ventilation. Thus, a battery of measures of
cardiac function might provide a more comprehensive
assessment of cardiovascular response to exercise.
The aim of this study was to investigate whether in
COPD patients at any stage of disease, there is a rela-
tionship between dynamic hyperinflation and cardiovas-
cular response to maximal exercise. Cardiovascular
response was assessed by change during exercise in
O2Pulse and in DP and by the OUES.
Methods
Subjects
We enrolled all consecutive patients suffering from
COPD, defined according to GOLD criteria [9], referred
for cardiopulmonary exercise testing (CPET) as part of a
comprehensive functional evaluation between September
2010 and May 2011. All patients were smokers or ex
smokers and they were on a stable optimized treatment
for at least 1 month at the time of the study. Eligibility
criteria were: 1) no clinical history of concomitant car-
diac heart failure or anaemia 2) ability to perform a
symptom-limited cycle ergometry cardio pulmonary test
with a peak of respiratory exchange ratio (RER) ≥ 1.05
in order to exclude poor motivation 3) CPET stopped
for fatigue and/or dyspnoea. All the procedures and
their risks were explained to the patients, who gave
their informed consent to enter the study. The pulmon-
ary function testing as well as the exercise studies had
been undertaken for clinical reasons at the request of
the patient’s clinician and the protocol was approved by
the ethical review committee of the University Hospital
of Parma.
Pulmonary function testing
Pulmonary function tests were performed according to
international recommendations [10-12]. A flow-sensing
spirometer and a body plethysmograph connected to a
computer for data analysis (Vmax 22 and 6200, Sensor
Medics, Yorba Linda, U.S.A.) were used for the mea-
surements. Vital Capacity (VC), Forced Expiratory
Volume at 1st Second (FEV1), Forced Expiratory Flow
measured at 50% of FVC (FEF50 in L/s) and Forced
Inspiratory Flow measured at 50% of FVC (FIF50 in L/s)
were recorded. FEV1/VC and FEF50/FIF50 ratios were
taken as indices of airway obstruction and airway collap-
sibility, respectively.
Thoracic gas volume (TGV) was measured by body
plethysmography with the subject panting against a
closed shutter at a frequency slightly < 1 Hz and their
cheeks supported by their hands. Total Lung Capacity
(TLC) was obtained as the sum of TGV and linked
Inspiratory Capacity (IC). IC/TLC was taken as an index
of static hyperinflation of the lung.
At least three measurements were made for each
spirometry and lung volume variable to ensure reprodu-
cibility and the highest value was used in subsequent
calculations. The flow-sensor was calibrated before each
test using a three-litre syringe.
Lung diffusion capacity for carbon monoxide (TLco)
was measured by the single breath method using a mix-
ture of carbon monoxide and methane and was mea-
sured at least in duplicate. TLC, VC, IC, FEV1 and TLco
were expressed as a percentage of the predicted values,
which were obtained from regression equations by
Quanjer et al [13] and Cotes et al [14].
Cardiopulmonary exercise test
CPET was performed according to a standardized proce-
dure [15]. After calibration of the oxygen and carbon
dioxide analyzers and flow mass sensor, patients were
asked to sit on an electromagnetically braked cycle erg-
ometer (Corival PB, Lobe Bv, Groningen, The Nether-
lands) and the saddle was adjusted properly to avoid the
maximal extension of the knee. The exercise protocol
involved an initial 3 minutes of rest, followed by
unloaded cycling for another 3 minutes with an incre-
ment every minute of 5-15 W, according to anthropo-
metric data and functional impairment degree of the
patients, in order to perform an exercise time lasting 8-
12 min. Patients were asked to maintain a pedalling fre-
quency of 60 rpm indicated by a digital display placed
on the monitor of the ergometer. Breath-by-breath VO2
(L/min), VCO2 (L/min) and minute VE (L/min) were
collected during the test (CPX/D; Med Graphics, St
Paul, MN, U.S.A.). Patients were continuously moni-
tored by a 12-lead electrocardiogram (Welch Allyn Car-
dioPerfect, Delft, The Nederlands) and a pulse oximeter
(Pulse Oximeter 8600, Nonin Medical Inc, MPLS, Mn
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U.S.A.). Blood pressure was measured at 2 min intervals.
Stopping criteria consisted of symptoms such as unsus-
tainable dyspnoea or leg fatigue, chest pain, ECG ST-
segment depression, a drop in systolic blood pressure or
oxygen saturation (SpO2) ≤ 84%.
Peak workload and peak VO2 were recorded as the
mean value of watts and VO2 during the last 20 s of the
test. Peak VO2 was expressed as absolute value in mL/
kg/min and as percent of predicted value [16].
Changes in operational lung volumes were evaluated
from measurements of IC at rest, every 3 min during
exercise and at peak exercise. After a full explanation to
each patient, satisfactory technique and reproducibility of
IC manoeuvres were established during an initial practice
session at rest. Assuming that TLC remains constant
during exercise in COPD [17], changes in IC reflect
changes in end-expiratory lung volume (EELV = TLC-
IC). EELV was expressed as percent of TLC for analysis.
Patients were divided in two groups according to the
EELV (%TLC) at peak of exercise; the group with a EELV
(%TLC) ≥ 75% was defined “heavy hyperinflators”.
The cardiovascular response to exercise was expressed
by the following parameters: O2Pulse change (ΔO2Pulse),
DP reserve and OUES. O2Pulse (mL/bpm) was calculated
by dividing instantaneous oxygen uptake by the heart rate
[16]. ΔO2Pulse was calculated as follows: O2Pulse at maxi-
mal exercise minus O2Pulse at rest. DP (mmHg·bpm) at
rest and at maximal exercise was calculated by the product
of systolic blood pressure and heart rate [18]. DP reserve
was calculated as follows: DP at maximal exercise minus
DP at rest. The OUES describes the relationship between
VO2 and VE during incremental exercise, via a log trans-
formation of VE and was expressed as the gradient of the
linear relationship of log10 VE to VO2 (L/min) [8].
Dyspnoea
Chronic activity-related dyspnoea was evaluated with the
Italian version of a five-point MRC scale modified by
the ATS [19].
Dyspnoea induced by CPET was measured at the end
of the incremental exercise by a 0-100 visual analogue
scale (VAS) [20]. Dyspnoea perception ratings were then
divided by the maximal workload (VAS/MW in mm/
watts) for analysis.
Statistical analysis
Data are reported as mean ± standard deviation (SD),
unless otherwise specified. The distribution of variables
was assessed by means of Kolmogorov-Smirnov Good-
ness-of-Fit test. Relationships between variables were
assessed by the Pearson’s correlation coefficient (r) and
linear regression analysis. Comparisons between vari-
ables were determined by unpaired t-test or by Chi-
square test, when appropriate.
The receiver operating characteristic (ROC) curve
method [21] was used to plot the true positive rate (sen-
sitivity) in function of the false positive rate (1-specifi-
city) for different cut-off points of ΔO2Pulse and DP
reserve with respect to a EELV (%TLC) ≥ 75% as a
threshold value.
A p value of less than 0.05 was taken as significant.
Results
We screened 55 consecutive patients (18 females) with
stable COPD, aged between 39 and 81 years. Seven
patients did not fall within the inclusion criteria. Demo-
graphic and clinical characteristics of the 48 patients
included in the study are shown in Table 1. At study
entry, patients were receiving inhaled steroids (75%),
long-acting beta2-agonists (75%) and Tiotropium (65%);
all of them were ex-smokers. Overall, a wide range of
airflow obstruction (FEV1/VC from 29 to 68%), airway
collapsibility (FEF50/FIF50 ratio from 0.09 to 0.94 L/s),
lung hyperinflation (IC/TLC ratio from 0.19 to 0.63 L),
diffusing capacity (TLco from 38 to 105%) and chronic
activity-related dyspnea (MRC from 0 to 4) were found
(Table 1).
Twenty-five (8 females) out of 48 patients (52%) suf-
fered from arterial hypertension and were on diuretics
(72%), ACE-inhibitors (52%), Ca-antagonists (36%), beta-
blockers (28%) to control the disease.
All patients completed the exercise test; at the peak
workload was 75 watt ± 24 (range 33-128 watt) without
any complication. Mean peak VO2 values were 15.3 ±
3.2 (range 10.6-22.5) and 63 ± 16 (range 33-112), when
expressed respectively in mL/kg/min and as percent of
predicted value. Mean VAS/MW was 1.25 mm/watts ±
0.48 (range 0.51-2.94). There was a statistically signifi-
cant fall in the SpO2, from 95.6% ± 1.4 (range 93-98%)
to 94.9% ± 2.1 (range 89-98%) (p = 0.007). Mean resting
IC and EELV (%TLC) were 2.27 L ± 0.69 (82 ± 19% of
predicted) and 66.5% ± 9.5, and significantly changed by
+0.38 L ± 0.41 (range -1.36 to 0.53 L; p < 0.0001) and
-7.88% ± 8.51 (range -7.90 to 30.4%; p < 0.0001),
respectively.
EELV (%TLC) at peak exercise was 72% ± 11, being ≥
75% in 23 out of 48 patients. Patients with a peak exer-
cise EELV (%TLC) ≥ 75% showed significantly lower
FEV1/VC, FEF50/FIF50 ratio and IC/TLC ratio compared
with the others (Table 1).
When related to the resting lung function, EELV
(%TLC) showed a negative correlation with IC/TLC (r =
- 0.871, p < 0.0001), FEV1/VC (r = - 0.435, p = 0.002), and
FEF50/FIF50 (r = - 0.391, p = 0.006). Moreover, it was sig-
nificantly and inversely related to peak workload (r =
- 0.540, p < 0.0001) and peak VO2 (r = - 0.452, p = 0.001)
and directly related to VAS/MW (r = 0.501, p = 0.0002).
Tzani et al. Respiratory Research 2011, 12:150
http://respiratory-research.com/content/12/1/150
Page 3 of 8
At baseline and at peak of exercise, mean O2Pulse and
DP were 3.69 mL/bpm ± 1.36 and 9.63 mL/bpm ± 2.68
and 10,746 mm Hg · bpm ± 2,664 and 21,006 mmHg ·
bpm ± 5,154, respectively. ΔO2Pulse, DP reserve and
OUES were 5.94 mL/bpm ± 2.03, 10,431 mmHg · bpm
± 4,165, and 1.39 L/min ± 0.33, respectively. Patients
with a peak exercise EELV (%TLC) ≥ 75% showed sig-
nificantly lower ΔO2Pulse, OUES and DP reserve values
compared to others (Table 1). Furthermore, SpO2 values
at peak exercise were significantly lower in the heavy
hyperinflators, as compared to those of the remaining
patients (Table 1).
EELV (%TLC) showed a negative correlation with
ΔO2Pulse (r = - 0.476, p = 0.001) (Figure 1), OUES (r =
- 0.452, p = 0.001) (Figure 2) and DP reserve (r = -
0.425, p = 0.004) (Figure 3).
According to the ROC curve method, the plot of the
true positive rate in function of the false positive rate for
different cut-off points of ΔO2Pulse change and DP
reserve with respect to EELV (% TLC) ≥ 75% as a thresh-
old value showed respectively 0.703 (p = 0.016) and 0.767
(p = 0.002) area under curve value. The ΔO2Pulse change
and DP reserve cut-off points, which maximized sensitiv-
ity and specificity, were ≤ 5.5 mL/bpm (0.640 sensitivity
and 0.696 specificity) and ≤ 10,000 mmHg · bpm (0.720
sensitivity and 0.783 specificity), respectively.
In addition, in patients with a DP reserve ≤ 10,000
mmHg · bpm, as compared to those of patients with DP
reserve > 10,000, VAS/MW values were significantly
higher (1.471 mm/watts ± 0.52 vs 1.045 mm/watts ±
0.34; p = 0.001). In all patients, VAS/MW values were
significantly and negatively related to DP reserve values
(r = -0.414; p = 0.008) (Figure 4).
Table 1 Demographic, baseline and exercise characteristics of COPD patients
All Patients (n = 48) Patients with
EELV ≥ 75% TLC
(n = 23)
Patients with
EELV < 75% TLC
(n = 25)
Mean ± SD Range Mean ± SD Range Mean ± SD Range p*
Age (yr) 68 ± 8 39-81 70 ± 7 57-81 67 ± 10 39-81 0.263
Females/Males 16/32 – 7/16 – 9/16 – 0.894
BMI (kg/m2) 26 ± 4 19-36 26 ± 4 20-34 26 ± 4 19-36 0.889
VC (% pred) 84 ± 16 55-124 81 ± 14 55-100 87 ± 18 60-124 0.199
FEV1 (% pred) 55 ± 13 33-81 47 ± 10 33-65 62 ± 12 34-81 0.001
TLC (% pred) 118 ± 20 80-177 127 ± 19 88-177 111 ± 17 80-139 0.004
TLco (% pred) 68 ± 17 38-105 65 ± 19 38-105 72 ± 15 39-99 0.137
FEV1/VC (%) 51 ± 12 29-68 46 ± 12 29-67 56 ± 9 36-68 0.003
FEF50/FIF50 ratio (L/s) 0.41 ± 0.22 0.09-0.94 0.31 ± 0.18 0.09-0.88 0.49 ± 0.21 0.22-0.94 0.003
IC/TLC ratio (L) 0.33 ± 0.10 0.19-0.63 0.26 ± 0.04 0.19-0.36 0.40 ± 0.09 0.24-0.63 0.001
HR rest 81 ± 16 47-114 83 ± 17 52-114 80 ± 16 47-108 0.486
HR peak 118 ± 18 71-150 115 ± 21 71-147 121 ± 16 93-150 0.299
Sp O2 rest 95.6 ± 1.4 93-98 95.3 ± 1.5 93 - 98 95.8 ± 1.2 93 - 98 0.177
Sp O2 peak 94.9 ± 2.1 89-98 93.8 ± 2.3 89 - 98 95.8 ± 1.2 94 - 98 0.0004
Peak VO2 (mL/kg/min) 15.3 ± 3.2 10.6-22.5 14.1 ± 3.1 10.6-22.5 16.4 ± 2.9 11.5-21.0 0.012
Peak workload (watts) 75 ± 24 33-128 64 ± 22 33-106 85 ± 21 47-128 0.001
VAS/MW (mm/watts) 1.25 ± 0.5 0.51-2.94 1.07 ± 0.3 0.63-1.76 1.44 ± 0.56 0.51-2.94 0.006
ΔO2Pulse (mL/bpm) 9.63 ± 2.68 5.0-15.0 8.65 ± 2.21 5.0-15.0 10.52 ± 2.80 6.0-15.0 0.014
DP reserve (mm Hg · bpm) 10,431 ± 4,165 1,460-20,560 8,509 ± 3,537 1,460-16,740 12,074 ± 3,862 4,360-20,560 0.017
*p value: patients with EELV ≥ 75% TLC vs patients with EELV < 75% TLC
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Figure 1 Relationship between oxygen pulse change from rest
to peak exercise (ΔO2 Pulse) and EELV (%TLC) at peak of
exercise in the study population. Horizontal and vertical
interrupted lines correspond to 5.5 mL/bpm ΔO2 Pulse value and to
75% EELV of TLC value, respectively. According to the ROC curve
method, a ΔO2 Pulse ≤ 5.5 mL/bpm was the cut-off point, which
maximized sensitivity and specificity (0.640 and 0.696, respectively)
with respect to EELV (% TLC) ≥ 75%, as a threshold value.
Continuous line is the linear regression line.
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In all patients, a significant correlation between
O2Pulse at peak exercise (r = 0.481, p = 0.0006),
ΔO2Pulse (r = 0.458, p = 0.001), DP reserve (r = 0.295,
p = 0.046), OUES (r = 0.404, p = 0.005) and resting IC/
TLC was found.
Hypertensive patients did not differ from normoten-
sive patients both in terms of resting and exercise
values, including the ΔO2Pulse, DP and OUES.
Discussion
The main finding of the present study is that dynamic
hyperinflation is strictly associated to a poor cardiovascular
response to exercise in COPD patients with different
degree of severity. This finding supports the view that in
COPD patients, dynamic hyperinflation may affect exercise
performance not only by impairing ventilation, but also
cardiac function. In addition, this study confirmed that
dynamic hyperinflation is related to baseline lung function
and to a poor exercise performance, both in terms of work-
load and oxygen uptake.
In larger population studies, it has been shown that
more than 80% of COPD patients had a significant
decrease in IC during incremental work rate cycle exer-
cise [1,22] which varied inversely with the level of rest-
ing hyperinflation [22]. We have now confirmed and
extended that finding by providing the evidence that
dynamic hyperinflation, as assessed by EELV at peak of
exercise, was inversely related to resting hyperinflation
and to airway obstruction and collapsibility. It is of note
that, in COPD patients, airway collapsibility is due to
the calibre of intraparenchymal airways which is much
less on expiration than on inspiration because of the
lack of parenchymal support in the peripheral airways,
as a consequence of disruption of the elastic network of
the lung. Airway collapsibility, indeed, expressed as the
FEF50/FIF50 ratio, was found significantly and inversely
related to the extent of pulmonary emphysema, as
assessed by means of lung scan [23].
In line with previous studies [22,24], we found that
dynamic hyperinflation was inversely related to the
extent of exercise capacity. Interestingly, we also demon-
strated that in COPD patients dynamic hyperinflation
was associated with a poor cardiovascular response to
exercise. Previously, in a large cohort of COPD patients,
a strong positive correlation between resting IC/TLC
ratio and the left ventricular end-diastolic diameter was
found [25]. Butler et al [26] showed that in COPD
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Figure 2 Relationship between oxygen uptake efficiency slope
(OUES) during exercise and EELV (TLC) at peak of exercise in
the study population. Continuous line is the linear regression line.
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Figure 3 Relationship between double product change from
rest to peak exercise (DP reserve) and EELV (%TLC) at peak of
exercise in the study population. Horizontal and vertical
interrupted lines correspond to 10,000 mmHg · bpm DP reserve
value and to 75% EELV of TLC value, respectively. According to the
ROC curve method, a DP reserve ≤ 10,000 mmHg · bpm was the
cut-off point, which maximized sensitivity and specificity (0.720 and
0.783, respectively) with respect to EELV (% TLC) ≥ 75%, as a
threshold value. Continuous line is the linear regression line.
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Figure 4 Relationship between breathlessness perception, as
corrected for workload in watts, at peak of exercise (VAS/MW)
and DP reserve values in the study population. Continuous line
is the linear regression line.
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patients exercising in supine position, the raised wedge
pressure was partly due to a rise in pressure in the car-
diac fossa associated with lower lobe gas trapping. It is
of note that left ventricular dysfunction, echocardiogra-
phically measured, was associated with a reduced physi-
cal activity in COPD patients [27].
Recently, in a cohort of patients with severe COPD
Vassaux et al [5] found that both resting and peak exer-
cise IC/TLC ratios were associated with oxygen pulse.
In particular, patients with resting IC/TLC ≤ 25% had
lower peak oxygen pulse, as compared to patients with
IC/TLC > 25%. In addition, a significant and inverse
relationship was found between changes in IC and oxy-
gen pulse from rest to peak exercise. In the present
study, we confirmed this finding in COPD patients with
a wide range of airflow obstruction, showing a signifi-
cant and inverse relationship between the peak exercise
EELV and the change in oxygen pulse achieved on exer-
cise. Moreover, the change in oxygen pulse during exer-
cise was lower in heavy hyperinflators than in the
remaining patients.
The oxygen pulse does not directly measure the stroke
volume, but it may be considered as a surrogate marker,
when arterial oxygen content can be assumed to be nor-
mal [6]. Accordingly, in normal subjects, exercise stroke
volume may be estimated simply as five times the slope
of the linear oxygen uptake-heart rate relationship [28].
Our study was non-invasively performed and, thus, we
did not measure the true arterial oxygen content in our
patients. Physiologically, the arterial oxygen content can
be affected by the availability of haemoglobin, blood
oxygenation in the lung and oxygen extraction in the
periphery. Notwithstanding, we excluded patients with
concomitant anaemia in our study, whereas the resting
oxygen saturation of patients was quite normal and its
change at peak exercise was statistically, but not clini-
cally, significant. In COPD patients, the oxygen extrac-
tion during exercise can be similar [29] or lower [30] as
compared to controls, however these differences cannot
account for the decrease in oxygen pulse, since a lower
oxygen extraction would actually magnify the oxygen
pulse value.
Dynamic hyperinflation may reduce left ventricle
stroke volume since increases intrathoracic pressures
and, consequently, decreases the preload by reducing
both venous return and the volume of the left ventricle.
As a consequence, there is a reduced filling of the left
ventricle and consequently a reduced cardiac output.
Interestingly, in very severe COPD patients, Montes de
Oca et al [31] found a direct relationship between
inspiratory intrathoracic pressures and oxygen pulse at
peak of exercise. In our study, we had a further evidence
of the effect of dynamic hyperinflation on left ventricle
stroke volume. Indeed and most important, we found
that DP reserve was inversely related to the dynamic
hyperinflation during exercise. In addition, heavy hyper-
inflators had a high likelihood to have a DP reserve
value ≤ 10,000 mmHg · bpm. Lastly, in all patients, DP
reserve was inversely related to breathlessness percep-
tion at peak exercise, suggesting that in COPD patients
the exertional dyspnoea may be due not only to ventila-
tory constrains, but also to a functional cardiovascular
impairment.
DP reserve is used as an estimate of the maximal per-
formance of the left ventricle. It would appear that the
capacity to achieve an adequate systolic blood pressure
requires a relatively normal functioning left ventricle
such that cardiac output increases in proportion to the
increase in work rate and that it can be sustained even
when exertion is near maximal [7]. DP reserve reflects
myocardial oxygen uptake during exercise, since the
three major determinants of myocardial oxygen uptake
are the tension in the wall of the ventricle, the contrac-
tile state of the heart and the heart rate [7]. Notably,
studies in healthy subjects [32] and in patients with
angina pectoris [18] showed that the myocardial oxygen
consumption during exercise can be reliably estimated
by the DP value. Interestingly, a DP reserve ≤ 10,000
mmHg · bpm is considered as a predictor of cardiovas-
cular mortality [7].
Finally, we also found that OUES was negatively asso-
ciated with hyperinflation at peak of exercise. The
OUES is the rate of increase of VO2 in response to a
given VE during incremental exercise [33]. OUES indi-
cates how effectively oxygen is extracted and taken into
the body and in essence represents the absolute rate of
increase in VO2 per 10-fold increase in ventilation.
OUES is a parameter that integrates the functional capa-
cities of several organ systems (primarily cardiovascular,
musculoskeletal and pulmonary) during exercise, since it
can be affected by the lactic acidosis onset, muscle
mass, oxygen extraction and utilization, and the physio-
logic pulmonary dead space ventilation. In the present
study, we found that for any given amount of ventila-
tion, the higher was hyperinflation the lower was oxygen
uptake during exercise (Figure 2). Therefore this finding
suggests that a reduced cardiovascular fitness is asso-
ciated to dynamic hyperinflation in COPD patients,
although we cannot exclude that some degree of decon-
ditioning may also affect the relationship between oxy-
gen uptake and ventilation during exercise in the most
hyperinflated patients.
Conclusions
In conclusion, the present study clearly shows that
COPD patients with dynamic hyperinflation have a poor
cardiovascular response to exercise. Although associa-
tion does not imply causality, our findings suggest that
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ventilatory constraints during exercise may play a rele-
vant role on cardiovascular function in patients with
COPD. These findings may also have some direct clini-
cal implication. In fact, it is likely that during rehabilita-
tion hyperinflated COPD patients might differently
behave and response to exercise, thus, having a different
impact on their disability and symptoms in the long-
term and it should be a field for further investigations.
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